Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kim

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Pain Medicine (Malden, Mass.)|January 28, 2016
Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic NeuralgiaAnne M Calkins, Jeff Gudin, Barry Gidal, et al.
Cancer|June 28, 2012
Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinomaHao Xie, Wei Jiang, John Jiang, et al.
Journal of Clinical Movement Disorders|January 21, 2016
Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trialsWilliam G Ondo, Neal Hermanowicz, Diego García Borreguero, et al.
Molecular Pharmacology|August 16, 2002
Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agentsErin Schuetz, Lubin Lan, Kazuto Yasuda, et al.
CNS Drugs|April 21, 2016
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled TrialsNeal Hermanowicz, Aaron Ellenbogen, Gordon Irving, et al.
Investigational New Drugs|January 24, 2015
Everolimus and pasireotide for advanced and metastatic hepatocellular carcinomaHanna K Sanoff, Richard Kim, Anastasia Ivanova, et al.
Neuro-Oncology|May 22, 2012
Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesisErin M Walsh, Richard Kim, Luis Del Valle, et al.
Human Pathology|February 5, 2011
Insulin-like growth factor I receptor β expression in hepatocellular carcinomaXiuli Liu, Wei Jiang, Federico Aucejo, et al.
Cancer|January 26, 2011
Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancerRichard Kim, Ann Tan, Kevin K Lai, et al.
Oncology|November 13, 2010
Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantationRichard Kim, Galal El-Gazzaz, Ann Tan, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Pain Medicine (Malden, Mass.)|January 28, 2016
Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic NeuralgiaAnne M Calkins, Jeff Gudin, Barry Gidal, et al.
Cancer|June 28, 2012
Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinomaHao Xie, Wei Jiang, John Jiang, et al.
Journal of Clinical Movement Disorders|January 21, 2016
Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trialsWilliam G Ondo, Neal Hermanowicz, Diego García Borreguero, et al.
Molecular Pharmacology|August 16, 2002
Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agentsErin Schuetz, Lubin Lan, Kazuto Yasuda, et al.
CNS Drugs|April 21, 2016
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled TrialsNeal Hermanowicz, Aaron Ellenbogen, Gordon Irving, et al.
Investigational New Drugs|January 24, 2015
Everolimus and pasireotide for advanced and metastatic hepatocellular carcinomaHanna K Sanoff, Richard Kim, Anastasia Ivanova, et al.
Neuro-Oncology|May 22, 2012
Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesisErin M Walsh, Richard Kim, Luis Del Valle, et al.
Human Pathology|February 5, 2011
Insulin-like growth factor I receptor β expression in hepatocellular carcinomaXiuli Liu, Wei Jiang, Federico Aucejo, et al.
Cancer|January 26, 2011
Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancerRichard Kim, Ann Tan, Kevin K Lai, et al.
Oncology|November 13, 2010
Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantationRichard Kim, Galal El-Gazzaz, Ann Tan, et al.
Pageof 21